Serum anticholinergicity is associated with reduced prefrontal brain function in early course schizophrenia

This publication has 20 references indexed in Scilit:

• Prefrontal gray matter morphology mediates the association between serum anticholinergicity and cognitive functioning in early course schizophrenia
  Psychiatry Research, 2012
• The Cognitive Cost of Anticholinergic Burden: Decreased Response to Cognitive Training in Schizophrenia
  American Journal of Psychiatry, 2009
• Meta-analysis of 41 Functional Neuroimaging Studies of Executive Function in Schizophrenia
  Archives of General Psychiatry, 2009
• Lateral and Medial Hypofrontality in First-Episode Schizophrenia: Functional Activity in a Medication-Naive State and Effects of Short-Term Atypical Antipsychotic Treatment
  American Journal of Psychiatry, 2005
• Decreased Conflict- and Error-Related Activity in the Anterior Cingulate Cortex in Subjects With Schizophrenia
  American Journal of Psychiatry, 2005
• Antipsychotic and anticholinergic effects on two types of spatial memory in schizophrenia
  Schizophrenia Research, 2004
• Association of Anticholinergic Load With Impairment of Complex Attention and Memory in Schizophrenia
  American Journal of Psychiatry, 2004
• Central Muscarinic Acetylcholine Receptor Availability in Patients Treated with Clozapine
  Neuropsychopharmacology, 2003
• Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.
  Neuropsychology, 1998
• Serum Levels of Anticholinergic Drugs in Treatment of Acute Extrapyramidal Side Effects
  Archives of General Psychiatry, 1980